SHIP1 MODULATORS AND METHODS RELATED THERETO SHIP1

R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 modulators, and thus may be useful in tre...

Full description

Saved in:
Bibliographic Details
Main Authors David BOGUCKI, Lloyd, F. MACKENZIE, Jeffery, R. RAYMOND, Thomas, B. MACRURY, Curtis HARWIG, Jeremy, D. PETTIGREW
Format Patent
LanguageChinese
English
Published 28.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 modulators, and thus may be useful in treating a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of the invention are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.
AbstractList R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 modulators, and thus may be useful in treating a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of the invention are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.
Author Lloyd, F. MACKENZIE
Jeremy, D. PETTIGREW
David BOGUCKI
Jeffery, R. RAYMOND
Thomas, B. MACRURY
Curtis HARWIG
Author_xml – fullname: David BOGUCKI
– fullname: Lloyd, F. MACKENZIE
– fullname: Jeffery, R. RAYMOND
– fullname: Thomas, B. MACRURY
– fullname: Curtis HARWIG
– fullname: Jeremy, D. PETTIGREW
BookMark eNrjYmDJy89L5WQwCvbwDDBU8PV3CfVxDPEPClZw9HNR8HUN8fB3CVYIcgUKuroohHi4BrmG-CuAFfMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkngPb0MjIwNDCwNHQ2MilAAAFn8n7g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 調節劑及與其相關的方法
ExternalDocumentID HK1220180A1
GroupedDBID EVB
ID FETCH-epo_espacenet_HK1220180A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:48:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HK1220180A13
Notes Application Number: HK20160108136
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170428&DB=EPODOC&CC=HK&NR=1220180A1
ParticipantIDs epo_espacenet_HK1220180A1
PublicationCentury 2000
PublicationDate 20170428
PublicationDateYYYYMMDD 2017-04-28
PublicationDate_xml – month: 04
  year: 2017
  text: 20170428
  day: 28
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies AQUINOX PHARMACEUTICALS (CANADA) INC
RelatedCompanies_xml – name: AQUINOX PHARMACEUTICALS (CANADA) INC
Score 3.203988
Snippet R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SHIP1 MODULATORS AND METHODS RELATED THERETO SHIP1
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170428&DB=EPODOC&locale=&CC=HK&NR=1220180A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkFmySTWIOQdJswmrNgySV3kqTbrEXLTYi-OudDWn1ordld9kXzM5-883MAtxUYqDPHNtUJXWr0rISKup1qg4qR6D-N82ykvaOKLb4mD5OzEkHlptYmCZP6GeTHBElqkJ5r5v7evVjxGKNb-X6tlxi1dt9WLhMadGxZksIoLChG6QJS3zF910-UuLM1XRdpqryECjt4Cvalt5fwfNQBqWsfmuU8BB2UxzstT6CztdLD_b9zcdrPdiLWr4bi63orY9Bz_lDqpEoYeMnr0iynHgxI1FQ8ITlRP58gXcQKXiQBUVCms4nQMKg8LmKk0-3G53y0XaZxil0Ef-LMyAWIkdnMRfzks5kOrGZsCS7SqlBS0tURh_6fw5z_k_bBRzIE5PUiH53Cd36_UNcoYaty-vmbL4B_d958A
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHstshGN-CwGFi3FPdFWDHcCBs1clEiMyb-9b4uA73orWmb14_kvddfX9-vAHe5bJuLftfSVehWp1kudfTrVG_nfYn-37KyXN13RLHNp_RxZs1qsNrmwpQ8oZ8lOSJqVI76XpT2ev1zicXKt5Wb-2yFVW8PvnCYVqFjo6sggMaGjjdOWOJqruvwQIsnjmGaiqpqgEBpD0_YPUWz7z0NVVLK-rdH8Y9gf4zCXotjqH29NKHhbj9ea8JBVMW7sVip3uYEzJSPxgaJEjYNByKZpGQQMxJ5gicsJernC7RBRHBv4omElJ1PgfiecLmOg893C53zYDfNzhnUEf_LcyA2Isf-81IuM7pQdGILaavoKqUdmtky77Sg9aeYi3_abqHBRRTOw1EcXMKh2j0VJjF7V1Av3j_kNXrbIrsp9-kb3Rd84A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SHIP1+MODULATORS+AND+METHODS+RELATED+THERETO+SHIP1&rft.inventor=David+BOGUCKI&rft.inventor=Lloyd%2C+F.+MACKENZIE&rft.inventor=Jeffery%2C+R.+RAYMOND&rft.inventor=Thomas%2C+B.+MACRURY&rft.inventor=Curtis+HARWIG&rft.inventor=Jeremy%2C+D.+PETTIGREW&rft.date=2017-04-28&rft.externalDBID=A1&rft.externalDocID=HK1220180A1